GF
ECF
PDX
GRX
ECAT

Saba Capital Management, L.P.

Known title: 10% OwnerCIK: 0001510281

Saba Capital Management, L.P.'s purchase track record

How the stock did after each of Saba Capital Management, L.P.'s open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.

Purchases measured
406
of 447 since September 27, 2021
Stock higher 6 months later
85%
3 months: 79%
Median 6-month return
+10.7%
3 months: +6.4%
Beat the S&P 500
40%
median -2.1% vs. index
PurchaseStockAmount3 months6 months
10/7/2026ECF$210Kpendingpending
10/5/2026GF$334Kpendingpending
10/1/2026MXF$910Kpendingpending
9/30/2026GRX$150Kpendingpending
9/25/2026GF$210Kpendingpending
7/17/2026GF$265K-8.1%pending
7/15/2026MXF$385K-6.8%pending
7/7/2026MXF$155K-5.6%pending
6/30/2026GF$508K-7.1%pending
6/22/2026GF$47-6.8%pending
6/17/2026MXF$550K-4.0%pending
6/11/2026GF$1.22M-1.0%pending
6/5/2026MXF$1.51M+2.6%pending
6/3/2026HFRO$1.21M+11.6%pending
5/29/2026GF$1.46M-3.7%pending
5/28/2026MXF$2.19M+0.1%pending
5/26/2026HFRO$935K+14.3%pending
5/21/2026GF$2.98M-3.2%pending
5/20/2026MXF$1.57M-0.1%pending
5/18/2026HFRO$619K+17.9%pending
5/13/2026GF$548K-0.5%pending
5/12/2026MXF$2.34M+0.4%pending
5/5/2026GF$342K-0.4%pending
5/1/2026MXF$70K+3.9%pending
4/17/2026GF$241K-5.4%-13.1%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

GF · New Germany Fund Inc. (The) Common StockGF insiders
ECF · Ellsworth Growth and Income Fund Ltd.ECF insiders
PDX · PIMCO Dynamic Income Strategy Fund Common Shares of Beneficial InterestPDX insiders
GRX · The Gabelli Healthcare & Wellness Trust Common Shares of Beneficial InterestGRX insiders
ECAT · BlackRock ESG Capital Allocation Term Trust Common Shares of Beneficial InterestECAT insiders
MXF · Mexico Fund Inc. (The) Common StockMXF insiders
HFRO · Highland Opportunities and Income Fund Common Shares of Beneficial InterestHFRO insiders
GF
GFNew Germany Fund Inc. (The) Common Stock
this person other insiders at GF
ECF
ECFEllsworth Growth and Income Fund Ltd.
this person other insiders at ECF

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 26, 2026

PDX Featured in SeekingAlpha's 10 Best CEFs List for September 2026. PDX was named one of SeekingAlpha's 10 best closed‑end funds for September 2026, with an average yield of about 10%. The fund sits near the lower end of its 52‑week range, and its RSI of 39.8 suggests it is not yet overbought. A recent volume spike and a support rejection at $20.63 may signal a short‑term test of that level.

PDX
PDXPIMCO Dynamic Income Strategy Fund Common Shares of Beneficial Interest
this person other insiders at PDX

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 27, 2026

Gabelli Healthcare & Wellness Trust Releases Q2 2026 Commentary. The Gabelli Healthcare & Wellness Trust has published its Q2 2026 commentary, providing an update on the trust's recent performance and outlook. This disclosure serves as a standard periodic update for stakeholders. The trust currently trades within a 52-week range of $8.80 to $10.20, with recent activity near the lower end of that band.

GRX
GRXThe Gabelli Healthcare & Wellness Trust Common Shares of Beneficial Interest
this person other insiders at GRX

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 1, 2026

ECAT: BlackRock Closed-End Funds Announce Distribution Sources. The trust announced that its closed‑end funds will distribute income from specific sources, giving investors clearer insight into where the cash flow comes from. Knowing the distribution origins can help assess the trust’s stability and potential return. The disclosure comes as the shares trade near a key support level and a low RSI, indicating a possible consolidation phase. Overall, the update adds transparency to the trust’s income profile.

ECAT
ECATBlackRock ESG Capital Allocation Term Trust Common Shares of Beneficial Interest
this person other insiders at ECAT
MXF
MXFMexico Fund Inc. (The) Common Stock
this person other insiders at MXF
HFRO
HFROHighland Opportunities and Income Fund Common Shares of Beneficial Interest
this person other insiders at HFRO

Transaction History

GF▲ Buy$13K
ECF▲ Buy$210K
PDX▼ Sell$75K
GRX▲ Buy$28K
ECAT▼ Sell$355K
PDX▼ Sell$291K
ECAT▼ Sell$131K
GF▲ Buy$58K
GRX▲ Buy$42K
PDX▼ Sell$239K
MXF▲ Buy$520K
GRX▲ Buy$17K
GF▲ Buy$264K
PDX▼ Sell$441K
MXF▲ Buy$31K
GRX▲ Buy$5K
ECAT▼ Sell$13K
PDX▼ Sell$489K
ECAT▼ Sell$34K
GRX▲ Buy$54K
MXF▲ Buy$358K
PDX▼ Sell$181K
GRX▲ Buy$5K
GF▲ Buy$118K
ECAT▼ Sell$338K
MXF▲ Buy$25K
ECAT▼ Sell$409K
GF▲ Buy$21K
MXF▲ Buy$86K
GF▲ Buy$14K
GF▲ Buy$56K
MXF▲ Buy$17K
MXF▲ Buy$22K
GF▲ Buy$5K
GF▲ Buy$51K
MXF▲ Buy$598K
GF▼ Sell$135K
MXF▲ Buy$2K
GF▼ Sell$10K
MXF▲ Buy$43K
ECAT▼ Sell$417K
GF▲ Buy$153K
ECAT▼ Sell$303K
GF▲ Buy$14K
PDX▼ Sell$407K
ECAT▼ Sell$1.4M
MXF▲ Buy$132K
GF▲ Buy$17K
GF▲ Buy$36K
MXF▲ Buy$10K
ECAT▼ Sell$389K
ECAT▼ Sell$612K
GRX▲ Buy$4K
PDX▼ Sell$219K
PDX▼ Sell$253K
ECAT▼ Sell$1.7M
GF▲ Buy$9K
PDX▼ Sell$416K
ECAT▼ Sell$1.6M
ECAT▼ Sell$2.6M
PDX▼ Sell$230K
GF▲ Buy$14K
ECF▲ Buy$84K
ECAT▼ Sell$955K
GF▲ Buy$43K
GRX▲ Buy$5K
ECF▲ Buy$61K
ECAT▼ Sell$3.2M
ECAT▼ Sell$821K
GF▲ Buy$23K
GF▲ Buy$10K
ECAT▼ Sell$1.2M
ECAT▼ Sell$2.0M
ECAT▼ Sell$2.7M
ECF▲ Buy$15K
ECAT▼ Sell$1.4M
GRX▲ Buy$44K
ECF▲ Buy$49K
ECAT▼ Sell$1.2M
ECAT▼ Sell$516K
ECAT▼ Sell$1.0M
ECF▲ Buy$72K
GRX▲ Buy$72K
ECAT▼ Sell$458K
ECF▲ Buy$19K
GF▲ Buy$3K
GRX▲ Buy$244K
ECAT▼ Sell$1.1M
PDX▼ Sell$292K
ECAT▼ Sell$1.6M
ECAT▼ Sell$1.1M
GRX▲ Buy$12K
ECAT▼ Sell$699K
ECAT▼ Sell$3.0M
MXF▲ Buy$63K
ECAT▼ Sell$2.4M
GRX▲ Buy$2K
ECAT▼ Sell$1.9M
GF▲ Buy$55K
ECAT▼ Sell$3.3M
ECAT▼ Sell$2.6M
ECAT▼ Sell$2.1M
GF▲ Buy$3K
ECAT▼ Sell$654K
GF▲ Buy$21K
MXF▲ Buy$208K
ECAT▼ Sell$1.5M
GF▲ Buy$2K
ECAT▼ Sell$3.1M
MXF▲ Buy$4K
GF▲ Buy$8K
ECAT▼ Sell$2.4M
ECAT▼ Sell$2.8M
GF▲ Buy$1K
ECAT▼ Sell$2.4M
MXF▲ Buy$66K
ECAT▼ Sell$2.3M
MXF▲ Buy$56K
ECAT▼ Sell$2.3M
GF▲ Buy$4K
ECAT▼ Sell$702K
GF▲ Buy$425
ECAT▼ Sell$618K
MXF▲ Buy$9K
MXF▲ Buy$166K
ECAT▼ Sell$1.2M
ECAT▼ Sell$1.4M
MXF▲ Buy$4K
GF▲ Buy$259K
ECAT▼ Sell$1.3M
MXF▲ Buy$164K
ECAT▼ Sell$1.3M
MXF▲ Buy$12K
GF▲ Buy$6K
ECAT▼ Sell$513K
MXF▲ Buy$36K
ECAT▼ Sell$1.0M
MXF▲ Buy$2K
ECAT▼ Sell$1.7M
ECAT▼ Sell$904K
MXF▲ Buy$104K
ECAT▼ Sell$735K
ECAT▼ Sell$1.3M
ECAT▼ Sell$611K
MXF▲ Buy$11K
MXF▲ Buy$40K
ECAT▼ Sell$22K
GF▲ Buy$77K
ECAT▼ Sell$750K
ECAT▼ Sell$86K
GF▲ Buy$430K
ECAT▼ Sell$1.5M
GF▲ Buy$1K
ECAT▼ Sell$2.0M
ECAT▼ Sell$1.7M
ECAT▼ Sell$1.2M
ECAT▼ Sell$1.7M
ECAT▼ Sell$1.7M
MXF▲ Buy$109K
ECAT▼ Sell$1.4M
MXF▲ Buy$324K
ECAT▼ Sell$999K
GF▲ Buy$47
ECAT▼ Sell$625K
MXF▲ Buy$28K
ECAT▼ Sell$154K
GF▲ Buy$120K
MXF▲ Buy$90K
GF▲ Buy$340K
ECAT▼ Sell$919K
ECAT▼ Sell$921K
GF▲ Buy$625K
ECAT▼ Sell$304K
GF▲ Buy$125K
MXF▲ Buy$658K
GF▲ Buy$13K
MXF▲ Buy$111K
ECAT▼ Sell$2.9M
MXF▲ Buy$237K
ECAT▼ Sell$1.8M
ECAT▼ Sell$433K
HFRO▲ Buy$850K
MXF▲ Buy$76K
ECAT▼ Sell$510K
HFRO▲ Buy$45K
ECAT▼ Sell$863K
MXF▲ Buy$431K
HFRO▲ Buy$121K
MXF▲ Buy$694K
ECAT▼ Sell$170K
GF▲ Buy$734K
GF▲ Buy$1K
HFRO▲ Buy$189K
MXF▲ Buy$708K
ECAT▼ Sell$773K
HFRO▲ Buy$526K
MXF▲ Buy$214K
ECAT▼ Sell$846K
GF▲ Buy$660K
GF▲ Buy$1K

We use analytics to understand how market-wall is used. No personal data is sold.